Yesterday's big drop in gold stocks gives traders a terrific chance to buy today. Last Friday, I said to get ready for a "buy" signal in the gold sector. And now we have it. Let me explain… The Gold Miners Bullish Percent Index (or "BPGDM") turned higher from oversold conditions on Monday. And that's a green light for buying gold stocks. Here's the latest chart…
BPGDM measures the percentage of gold stocks that are trading in a bullish formation. It's a measure of overbought and oversold conditions for the sector. Readings above 80 – like we saw in July – indicate overbought conditions. Readings below 20 indicate oversold conditions in the gold sector.
best stock investments today: Seadrill Limited(SDRL)
Advisors’ Opinion:
- [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II - [By Paul Ausick]
SeaDrill Ltd. (NYSE: SDRL) dropped about 27.5% on Friday to record a new 52-week low of $1.21 against a high of $7.49. The stock closed at $1.67 on Thursday. Volume was more than double the daily average of around 14 million shares. The company had no specific news Friday.
- [By Dan Caplinger]
Rather than panicking, investors seemed to take the stance as a positive sign that the U.S. economy is ready for at least slightly less accommodative monetary policy going forward. Yet some stocks suffered sharp declines, and Shake Shack (NYSE:SHAK), Fred’s (NASDAQ:FRED), and Seadrill (NYSE:SDRL) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
- [By WWW.THESTREET.COM]
Shares of Seadrill (SDRL) were gaining by 12.46% to 91 cents in pre-market trading on Tuesday morning, after the offshore drilling contract provider said its subsidiary, North Atlantic Drilling, has secured a new 10 year contract.
best stock investments today: Ryerson Holding Corporation(RYI)
Advisors’ Opinion:
- [By Demitrios Kalogeropoulos]
As for individual stocks, PriceSmart (NASDAQ:PSMT) and Ryerson (NYSE:RYI)attracted heavy investor interest in the wake of their quarterly earnings reports.
- [By Dan Caplinger]
Among the worst performers on the day were GameStop (NYSE:GME), Hovnanian Enterprises (NYSE:HOV), and Ryerson Holding (NYSE:RYI). Below, we’ll look more closely at these stocks to explain why they did so poorly.
- [By Lisa Levin]
Shares of Ryerson Holding Corp (NYSE: RYI) got a boost, shooting up 11 percent to $13.70. Ryerson expects Q1 net income of $12 million to $15 million.
best stock investments today: Vanguard Short-Term Corporate Bond ETF(VCSH)
Advisors’ Opinion:
- [By Todd Shriber, ETF Professor]
and the Vanguard Short Term Corporate Bond ETF (NASDAQ: VCSH).
Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).
- [By WWW.GURUFOCUS.COM]
For the details of SWISS RE LTD’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=SWISS+RE+LTD
These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,641,300 shares, 34.54% of the total portfolio. Shares added by 6.79%SPDR S&P 500 (SPY) – 1,003,200 shares, 20.97% of the total portfolio. Shares reduced by 34.15%iShares MSCI EAFE (EFA) – 2,800,100 shares, 15.78% of the total portfolio. Shares added by 170.34%iShares 1-3 Year Credit Bond ETF (CSJ) – 1,659,000 shares, 15.1% of the total portfolio. New PositionVanguard Short-Term Corporate Bond ETF (VCSH) – 937,000 shares, 6.48% of the total po
best stock investments today: Caesars Acquisition Company(CACQ)
Advisors’ Opinion:
- [By Travis Hoium]
The big unknown with Caesars Entertainment is how the company’s proposed acquisition of Caesars Acquisition Company (NASDAQ:CACQ) and the resolution of Caesars Entertainment Operating Company’s bankruptcy will end up.
best stock investments today: VIVUS, Inc.(VVUS)
Advisors’ Opinion:
- [By Keith Speights]
Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.
- [By Peter Graham]
A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:
